Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
DOI
 |
|
Open Access Green as soon as Postprint is submitted to ZB.
A systematic review of Markov models evaluating multicomponent disease management programs in diabetes.
Expert Rev. Pharmacoecon. Outcomes Res. 15, 961-984 (2015)
Diabetes is the most expensive chronic disease; therefore, disease management programs (DMPs) were introduced. The aim of this review is to determine whether Markov models are adequate to evaluate the cost–effectiveness of complex interventions such as DMPs. Additionally, the quality of the models was evaluated using Philips and Caro quality appraisals. The five reviewed models incorporated the DMP into the model differently: two models integrated effectiveness rates derived from one clinical trial/meta-analysis and three models combined interventions from different sources into a DMP. The results range from cost savings and a QALY gain to costs of US$85,087 per QALY. The Spearman’s rank coefficient assesses no correlation between the quality appraisals. With restrictions to the data selection process, Markov models are adequate to determine the cost–effectiveness of DMPs; however, to allow prioritization of medical services, more flexibility in the models is necessary to enable the evaluation of single additional interventions.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Review
Keywords
Review ; Markov Model ; Diabetes ; Dmp ; Quality Assessment ; Economic Evaluation ; Cost-effectiveness
ISSN (print) / ISBN
1473-7167
e-ISSN
1744-8379
Quellenangaben
Volume: 15,
Issue: 6,
Pages: 961-984
Publisher
Taylor & Francis
Publishing Place
London
Non-patent literature
Publications
Reviewing status
Peer reviewed